GT200600365A - Aciltriptofanoles - Google Patents
AciltriptofanolesInfo
- Publication number
- GT200600365A GT200600365A GT200600365A GT200600365A GT200600365A GT 200600365 A GT200600365 A GT 200600365A GT 200600365 A GT200600365 A GT 200600365A GT 200600365 A GT200600365 A GT 200600365A GT 200600365 A GT200600365 A GT 200600365A
- Authority
- GT
- Guatemala
- Prior art keywords
- aciltriptofanoles
- anthogonists
- aciltriptophenols
- fsh
- fertility
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005038632A DE102005038632B4 (de) | 2005-08-10 | 2005-08-10 | Acyltryptophanole |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600365A true GT200600365A (es) | 2007-04-02 |
Family
ID=37681170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600365A GT200600365A (es) | 2005-08-10 | 2006-08-09 | Aciltriptofanoles |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR056190A1 (de) |
DE (1) | DE102005038632B4 (de) |
DO (1) | DOP2006000187A (de) |
GT (1) | GT200600365A (de) |
PE (1) | PE20070406A1 (de) |
TW (1) | TW200716098A (de) |
UY (1) | UY29737A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008025893B4 (de) * | 2008-05-26 | 2014-09-18 | Technische Universität Dresden | Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren |
-
2005
- 2005-08-10 DE DE102005038632A patent/DE102005038632B4/de not_active Expired - Fee Related
-
2006
- 2006-08-09 GT GT200600365A patent/GT200600365A/es unknown
- 2006-08-10 DO DO2006000187A patent/DOP2006000187A/es unknown
- 2006-08-10 PE PE2006000971A patent/PE20070406A1/es not_active Application Discontinuation
- 2006-08-10 TW TW095129439A patent/TW200716098A/zh unknown
- 2006-08-10 UY UY29737A patent/UY29737A1/es not_active Application Discontinuation
- 2006-08-10 AR ARP060103506A patent/AR056190A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
UY29737A1 (es) | 2007-02-28 |
DE102005038632B4 (de) | 2008-03-27 |
DOP2006000187A (es) | 2007-03-15 |
DE102005038632A1 (de) | 2007-02-15 |
AR056190A1 (es) | 2007-09-26 |
TW200716098A (en) | 2007-05-01 |
PE20070406A1 (es) | 2007-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2009000094A (es) | Inhibidores de la proteasa ns3 del hcv | |
NI200900069A (es) | Inhibidores de la proteasa ns3 del hcv | |
ATE498669T1 (de) | 2,6-naphthylreste enthaltende verbindungen | |
BRPI0414062A (pt) | uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv | |
BR0312575A (pt) | Moduladores do receptor de glicocorticóides | |
CR10433A (es) | Compuestos organicos y sus usos | |
ES2530991T3 (es) | Procedimiento para la obtención de betamiméticos | |
SG163585A1 (en) | Melanocortin receptor ligands | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
TN2009000398A1 (en) | 5,6-dihydro-1h-pyridin-2-one compounds | |
ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
ECSP056011A (es) | Derivados azabiciclicos de piridiloximetilo y bencisoxazol | |
BRPI0513317A (pt) | ciclosporinas para tratar doença de alzheimer | |
UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
CL2007002385A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento y/o profilaxis de enfermedades seleccionadas de infeccion por helicobacter pylori, pterigion, endometriosis, sindrome de hiperestimulacion ovarica y enfermedad del rinon poliquistico. | |
GT200600379A (es) | Composición farmacéutica sólida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph | |
CL2007001514A1 (es) | Compuestos derivados de triazina o diazina sustituida por cromano u isocromano, inhibidores de hsp90; composicion farmaceutica que comprende; y su uso en el tratamiento del cancer. | |
ATE521292T1 (de) | Vorrichtung zur reposition einer knochenfraktur | |
ATE554774T1 (de) | 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2 | |
CL2007003847A1 (es) | Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer. | |
DE602006012313D1 (de) | Kombination aus pyrimidylaminobenzamid-verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen | |
GT200600365A (es) | Aciltriptofanoles | |
UY38472A (es) | Moduladores de la expresión de foxp3 | |
ATE499942T1 (de) | 2-methylen-19,21-dinor-1alpha-hydroxy- bishomopregnacalciferol |